Journal profile · Pharmacology & Pharmacy
Journal of Pharmacokinetics and Pharmacodynamics
ISSN 1567-567X · eISSN 1573-8744 · Springer US · UNITED STATES · Bimonthly · Founded 1973
Journal of Pharmacokinetics and Pharmacodynamics: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.33; hybrid open access; APC about USD 4,390; median 131 days to acceptance (98 articles, last 24 months); community-reported acceptance: fairly easy; 57 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Pharmacokinetics and Pharmacodynamics is published by Springer US and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Statistical Methods in Clinical Trials, Pharmacogenetics and Drug Metabolism and Statistical Methods and Bayesian Inference, together about 32.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Broadly speaking, the Journal of Pharmacokinetics and Pharmacodynamics covers all areas of pharmacometrics and related disciplines, which includes (population) pharmacokinetics-pharmacodynamics, physiological-based pharmacokinetics (PBPK), systems pharmacology (QSP), and application of machine learning to pharmacokinetics-pharmacodynamics. The journal is devoted to all aspects of pharmacokinetics, pharmacodynamics, and the application of pharmacometrics to drug development and clinical care. The journal publishes on all topics related to pharmacometrics, including, but not limited to, clinical, experimental, and theoretical papers examining the kinetics of drug disposition and effects of drug action; modeling and simulation methodology; PBPK; QSP; precision medicine; and mathematical pharmacology (including computational biology, bioengineering, and biophysics related to pharmacology, pharmacokinetics, or pharmacodynamics). The journal does not strictly publish theoretical manuscripts. Clinical papers that include population pharmacokinetic-pharmacodynamic relationships are welcome, as are population pharmacokinetic papers of novel drugs or analyses with original methodology (without exposure-response analyses). The journal actively invites and promotes up-and-coming areas of pharmacometric research, such as real-world evidence and quality of life analyses. Journal of Pharmacokinetics and Pharmacodynamics publishes six issues a year.
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Editor-in-chief Peter L. BonatePublisher website
Editorial board by country: 1 in mainland China (about 2%); most named United States 30, United Kingdom 3, Germany 3, Switzerland 3, France 2 (55 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Statistical Methods in Clinical TrialsMathematics17.6%
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics7.7%
- Statistical Methods and Bayesian InferenceMathematics6.9%
- Computational Drug Discovery MethodsComputer Science6.8%
- Monoclonal and Polyclonal Antibodies ResearchMedicine6.5%
- Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology5.5%
- Antibiotics Pharmacokinetics and EfficacyMedicine5.2%
- Drug Transport and Resistance MechanismsMedicine4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.33LetPub ·
- Impact factor (publisher) 2025
- 3.3Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.2Publisher website ·
- CiteScore 2026-06
- 5.1LetPub ·
- SJR 2026-06
- 0.85LetPub ·
- SNIP 2026-06
- 0.93LetPub ·
- h-index
- 54LetPub ·
- h-index
- 77OpenAlex ·
- i10-index
- 651OpenAlex ·
- 2-year mean citedness
- 3.04OpenAlex ·
- Self-citation rate
- 6.1%LetPub ·
- Share of gold OA articles
- 49.31%LetPub ·
Volume
- Articles per year
- 52LetPub ·
- Downloads per year (publisher) 2025
- 403,500Publisher website ·
Articles by year OpenAlex count · 1,246 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 54 | 34 | 9 |
| 2025 | 57 | 30 | 190 |
| 2024 | 58 | 36 | 315 |
| 2023 | 56 | 34 | 519 |
| 2022 | 42 | 17 | 417 |
| 2021 | 68 | 38 | 1,001 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
131 daysMedian, submission to acceptance · P25–P75 96 days – 185 days
- Acceptance to online
- median 34 days (98 articles)
- Submission to online
- median 179 days
- Sample
- 98 articles with submission and acceptance dates (118 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to first decision
- 3 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,390 / EUR 3,590 / GBP 2,890 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Other fees
- Charged; see the journal's website for the amount
- Page charges
- Charged; see the journal's website for the amount
- Submission fee
- Charged; see the journal's website for the amount
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
- Graphical abstract
- Optional
Article types accepted2
- original paperOriginal Paper, Review Original Paper manuscript submissions should be organized into unnumbered sections that appear in the following order: Abstract Keywords …Length not stated
- reviewOriginal Paper, Review Original Paper manuscript submissions should be organized into unnumbered sections that appear in the following order: Abstract Keywords …Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Journal of Pharmacokinetics and Pharmacodynamics, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer US
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1973
- ISSN
- 1567-567X
- Electronic ISSN
- 1573-8744
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Pharmacokinetics and Pharmacodynamics
What CAS zone is Journal of Pharmacokinetics and Pharmacodynamics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Pharmacokinetics and Pharmacodynamics is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Pharmacokinetics and Pharmacodynamics?
The latest impact factor listed by LetPub is 3.33; CiteScore 5.1, h-index 77.
How long does peer review take at Journal of Pharmacokinetics and Pharmacodynamics?
Based on the dates recorded on 98 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 131 days (interquartile range 96–185 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Pharmacokinetics and Pharmacodynamics?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Suggested reviewers: Optional; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Pharmacokinetics and Pharmacodynamics based?
Of the 55 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are United States (30), United Kingdom (3) and Germany (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Pharmacokinetics and Pharmacodynamics?
According to LetPub and DOAJ records, Journal of Pharmacokinetics and Pharmacodynamics is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS and Current Contents; that list has not been checked against each database.
Is Journal of Pharmacokinetics and Pharmacodynamics open access, and what is the APC?
Journal of Pharmacokinetics and Pharmacodynamics is a hybrid journal. For open-access publication: APC about USD 4,390.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .